Tumor vaccine is a promising therapeutic strategy, which produces long-term anti-tumor immunity by stimulating immune responses accordingly. However, due to inefficient vaccination, the clinical efficacy of such vaccines is limited. Recently, inRead More…
Researchers at the Cleveland Clinic in the United States launched a new vaccine study aimed at eventually preventing triple negative breast cancer, a highly invasive and deadly form of cancer. The vaccineRead More…
With the mounting number of drug-resistant microbial infections, the epidemic outbreak of pathogenic bacteria, and the possible threat of new organisms in the future, the clinical intervention of infectious diseases is facingRead More…
In the clinical trial of oncolytic vesicular stomatitis virus expressing interferon-β (VSV-IFN-β), a large group of patients initially achieved a preliminary response, but then the disease relapsed. A few days ago, inRead More…
In a recent study, researchers from the University of Southampton in the UK inserted a gene into a harmless bacteria that allowed it to stay in the nose for a long timeRead More…
mRNA vaccine is to transfer RNA to the cells of the body to express and produce protein antigens, so as to induce the body to produce an immune response against the antigen,Read More…
Recently, the University of Oxford in the United Kingdom started a first phase clinical trial of a new HIV vaccine candidate in the United Kingdom. The trial, called HIV-CORE 0052, aims toRead More…
At present, a large-scale vaccination of COVID-19 is carrying out around the world, bringing hope for alleviating the epidemic situation of COVID-19’s. However, due to the menacing invasion of various SARS-CoV-2 variantsRead More…
Takeda Pharmaceutical recently announced that the European Drug Administration (EMA) has accepted the declaration of its dengue vaccine TAK-003, which is developed for people between the ages of 4 and 60 toRead More…
At present, new antigen vaccines have become a hot direction in the field of cancer immunotherapy. With the release of some positive clinical data and more and more projects entering the clinicalRead More…